TAFAZZIN and Barth syndrome: We have previously demonstrated successful in vivo AAV serotype 9 delivery of TAZ in a mouse model of BTHS that resulted in significant improvements in mitochondrial function, heart and skeletal muscle function, whole-body activity levels, and global cardiac proteomic profiles [19,20].